Literature DB >> 30003447

Influence of various medium environment to in vitro human T cell culture.

Hao Xu1, Na Wang1, Wenyue Cao1, Liang Huang1, Jianfeng Zhou1, Lingshuang Sheng2.   

Abstract

Nowadays, adoptive T cell immunotherapy is emerging as a novel and potent treatment for cancer. To prepare enough effective T cells for treatment use, their rapid expansion is favorable. Our study compared 6 commonly used cultural media for human T cells, including serum-containing media and serum-free media, namely RPMI 1640, IMDM, Gibco OpTmizer CTS T Cell Expansion SFM, Gibco AIM-V Medium CTS, LONZA X-VIVO 15, and StemSpan SFEM with or without Dynabeads Human T-Activator CD3/CD28, on in vitro T cell expansion, apoptosis, and immune phenotype. Our study results suggest that serum-free media provide better proliferation environment for T cells. Among the 3 serum-free media, we identify OpTmizer and AIM-V as better T cell culture environments compared with X-VIVO as T cells are proved to have higher viability in the first two media. Besides, we found that in vitro human T cells keep relatively resting status among non-CD3/CD28 groups, since they have weak proliferation and apoptosis abilities. The phenotypes of T cells in different cultural environments over time indicate T cells maturation during culture duration. These results provide a firm foundation of adoptive T cell immunotherapy.

Entities:  

Keywords:  Adoptive T cell therapy; Culture medium; Human T cells; In vitro culture; T cell phenotypes

Mesh:

Substances:

Year:  2018        PMID: 30003447     DOI: 10.1007/s11626-018-0273-3

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  19 in total

1.  Construction and preclinical evaluation of an anti-CD19 chimeric antigen receptor.

Authors:  James N Kochenderfer; Steven A Feldman; Yangbing Zhao; Hui Xu; Mary A Black; Richard A Morgan; Wyndham H Wilson; Steven A Rosenberg
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

Review 2.  Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans.

Authors:  A Moretta; E Ciccone; G Pantaleo; G Tambussi; C Bottino; G Melioli; M C Mingari; L Moretta
Journal:  Immunol Rev       Date:  1989-10       Impact factor: 12.988

3.  Impact of culture medium on the expansion of T cells for immunotherapy.

Authors:  Keisuke Sato; Makoto Kondo; Kazuko Sakuta; Akihiro Hosoi; Shuichi Noji; Miki Sugiura; Yukihiro Yoshida; Kazuhiro Kakimi
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

4.  Development of a serum-free medium for in vitro expansion of human cytotoxic T lymphocytes using a statistical design.

Authors:  Min Kyoung Jeon; Jong-Baeck Lim; Gyun Min Lee
Journal:  BMC Biotechnol       Date:  2010-09-21       Impact factor: 2.563

5.  Bioengineering and serum free expansion of blood-derived γδ T cells.

Authors:  Kathryn S Sutton; Anindya Dasgupta; David McCarty; Christopher B Doering; H Trent Spencer
Journal:  Cytotherapy       Date:  2016-07       Impact factor: 5.414

Review 6.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

Review 7.  Factors influencing the generation of murine dendritic cells from bone marrow: the special role of fetal calf serum.

Authors:  Manfred B Lutz; Susanne Rössner
Journal:  Immunobiology       Date:  2007-11-08       Impact factor: 3.144

8.  Hypercholesterolemia Enhances T Cell Receptor Signaling and Increases the Regulatory T Cell Population.

Authors:  Reiner K W Mailer; Anton Gisterå; Konstantinos A Polyzos; Daniel F J Ketelhuth; Göran K Hansson
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

9.  Performance of serum-supplemented and serum-free media in IFNgamma Elispot Assays for human T cells.

Authors:  Sylvia Janetzki; L Price; C M Britten; S H van der Burg; J Caterini; J R Currier; G Ferrari; C Gouttefangeas; P Hayes; E Kaempgen; V Lennerz; K Nihlmark; V Souza; A Hoos
Journal:  Cancer Immunol Immunother       Date:  2009-11-06       Impact factor: 6.968

10.  CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.

Authors:  Christian B Schiller; Todd A Braciak; Nadja C Fenn; Ursula J E Seidel; Claudia C Roskopf; Sarah Wildenhain; Annemarie Honegger; Ingo A Schubert; Alexandra Schele; Kerstin Lämmermann; Georg H Fey; Uwe Jacob; Peter Lang; Karl-Peter Hopfner; Fuat S Oduncu
Journal:  Oncotarget       Date:  2016-12-13
View more
  6 in total

Review 1.  A guide to interrogating immunometabolism.

Authors:  Kelsey Voss; Hanna S Hong; Jackie E Bader; Ayaka Sugiura; Costas A Lyssiotis; Jeffrey C Rathmell
Journal:  Nat Rev Immunol       Date:  2021-04-15       Impact factor: 108.555

2.  Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy.

Authors:  Hui Luo; Na Wang; Liang Huang; Xiaoxi Zhou; Jin Jin; Chunrei Li; Di Wang; Bin Xu; Jinhuan Xu; Lijun Jiang; Jue Wang; Yang Cao; Yi Xiao; Qian Zhang; Xia Mao; Songya Liu; Liting Chen; Min Xiao; Jianfeng Zhou
Journal:  J Immunother Cancer       Date:  2019-10-22       Impact factor: 13.751

Review 3.  Challenges of CRISPR-Based Gene Editing in Primary T Cells.

Authors:  Alaleh Rezalotfi; Lea Fritz; Reinhold Förster; Berislav Bošnjak
Journal:  Int J Mol Sci       Date:  2022-02-01       Impact factor: 5.923

Review 4.  Impact of Manufacturing Procedures on CAR T Cell Functionality.

Authors:  Norihiro Watanabe; Feiyan Mo; Mary Kathryn McKenna
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

5.  Phenotypic characteristics of peripheral immune cells of Myalgic encephalomyelitis/chronic fatigue syndrome via transmission electron microscopy: A pilot study.

Authors:  Fereshteh Jahanbani; Rajan D Maynard; Justin Cyril Sing; Shaghayegh Jahanbani; John J Perrino; Damek V Spacek; Ronald W Davis; Michael P Snyder
Journal:  PLoS One       Date:  2022-08-09       Impact factor: 3.752

6.  Neoantigen-specific CD4+ T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy.

Authors:  Peng Peng; Hongming Hu; Ping Liu; Lisa X Xu
Journal:  J Immunother Cancer       Date:  2020-09       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.